Skip to content
HowShorted

Acadia Healthcare Company, Inc. short interest in 2021

In 2021, Acadia Healthcare Company, Inc.'s disclosed short interest ran from 6.20% of shares outstanding on 15 Jan 2021 to 3.04% on 31 Dec 2021, a change of -3.16 percentage points. The year's high was 6.20% on 15 Jan 2021 and its low 2.82% on 30 Jul 2021, averaging 3.98% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.94 days on 29 Jan 2021. Full history: Acadia Healthcare Company, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Acadia Healthcare Company, Inc. in 2021

2021 in figures

Start of year
6.20% (15 Jan 2021)
End of year
3.04% (31 Dec 2021)
Change
-3.16 pp
High
6.20% (15 Jan 2021)
Low
2.82% (30 Jul 2021)
Average
3.98%
Highest days to cover
13.94 (29 Jan 2021)
SEC filings marked
8

Every report in 2021

Acadia Healthcare Company, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20216.20%11.73
29 Jan 20216.04%13.94
12 Feb 20216.12%10.41
26 Feb 20215.12%7.7910-K filed, results (8-K)
15 Mar 20215.05%6.66
31 Mar 20214.78%7.72
15 Apr 20214.71%12.47
30 Apr 20214.31%9.13results (8-K), 10-Q filed
14 May 20214.12%10.28
28 May 20213.90%10.78
15 Jun 20213.72%9.90
30 Jun 20213.32%7.01
15 Jul 20213.16%7.82
30 Jul 20212.82%7.62
13 Aug 20213.06%7.28results (8-K), 10-Q filed
31 Aug 20213.44%8.40
15 Sep 20213.59%7.82
30 Sep 20213.25%5.15
15 Oct 20213.26%6.36
29 Oct 20213.09%5.58results (8-K), 10-Q filed
15 Nov 20213.09%6.95
30 Nov 20213.14%9.09
15 Dec 20213.08%6.18
31 Dec 20213.04%7.94

See also: Acadia Healthcare Company, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.